Cat: PA1000-1481

Recombinant Human HOXA9 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    HOXA9

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    HOXA9;HOX1G;Homeobox Protein Hox-A9

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    His tag N-Terminus

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    P31269

  • 表达区间

    1-272aa

  • 氨基酸序列

    MATTGALGNYYVDSFLLGADAADELSVGRYAPGTLGQPPRQAATLAEHPD FSPCSFQSKATVFGASWNPVHAAGANAVPAAVYHHHHHHPYVHPQAPVAA AAPDGRYMRSWLEPTPGALSFAGLPSSRPYGIKPEPLSARRGDCPTLDTH TLSLTDYACGSPPVDREKQPSEGAFSENNAENESGGDKPPIDPNNPAANW LHARSTRKKRCPYTKHQTLELEKEFLFNMYLTRDRRYEVARLLNLTERQV KIWFQNRRMKMKKINKDRAKDE

  • 分子量

    56 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

HOXA9, a member of the homeobox gene family, plays a crucial role in hematopoiesis and is implicated in various types of malignancies, particularly in acute myeloid leukemia (AML). The gene is essential for the regulation of embryonic development and the maintenance of stem cell properties. Aberrant expression or mutations in HOXA9 can lead to dysregulation of stem cell differentiation and proliferation, contributing to oncogenesis. Recent studies have highlighted the significance of HOXA9 as a potential therapeutic target due to its role in cancer stem cell survival and resistance to chemotherapy. Research focused on the recombinant production of HOXA9 protein aims to elucidate its biochemical properties and functional mechanisms. By generating recombinant HOXA9, scientists can perform detailed characterizations and investigate its interactions with other proteins, as well as its regulatory pathways. This work not only enhances our understanding of HOXA9's role in normal and malignant hematopoiesis but also provides a framework for the development of targeted therapies that could improve treatment outcomes in patients with HOXA9-related malignancies. As such, the study of HOXA9 recombinant protein is pivotal for advancing cancer research and developing innovative therapeutic strategies.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US